相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades
Fangming Song et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Coupling factors and exosomal packaging microRNAs involved in the regulation of bone remodelling
Sipin Zhu et al.
BIOLOGICAL REVIEWS (2018)
The biology of normal bone remodelling
P. Katsimbri
EUROPEAN JOURNAL OF CANCER CARE (2017)
Asiaticoside hinders the invasive growth of keloid fibroblasts through inhibition of the GDF-9/MAPK/Smad pathway
Xin Wu et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2017)
Fructus Ligustri Lucidi in Osteoporosis: A Review of its Pharmacology, Phytochemistry, Pharmacokinetics and Safety
Beibei Chen et al.
MOLECULES (2017)
Monocytes, Macrophages, and Osteoclasts in Osteosarcoma
Fergal C. Kelleher et al.
JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY (2017)
Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling Pathways
Lin Zhou et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Asiaticoside attenuates diabetes-induced cognition deficits by regulating PI3K/Akt/NF-κB pathway
Zhujun Yin et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Asiaticoside attenuates lipopolysaccharide-induced acute lung injury via down-regulation of NF-κB signaling pathway
Jiaming Qiu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Asiaticoside attenuates the effects of spinal cord injury through antioxidant and anti-inflammatory effects, and inhibition of the p38-MAPK mechanism
Yang Luo et al.
MOLECULAR MEDICINE REPORTS (2015)
Treatment of post-menopausal osteoporosis: beyond bisphosphonates
S. Ishtiaq et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)
Prevention and treatment of postmenopausal osteoporosis
Sri Harsha Tella et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Neuroprotective effects of Asiaticoside
Feng-yan Qi et al.
NEURAL REGENERATION RESEARCH (2014)
Asiaticoside attenuates memory impairment induced by transient cerebral ischemia-reperfusion in mice through anti-inflammatory mechanism
She Chen et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Implications of Osteoblast-Osteoclast Interactions in the Management of Osteoporosis by Antiresorptive Agents Denosumab and Odanacatib
Natalie A. Sims et al.
CURRENT OSTEOPOROSIS REPORTS (2014)
Osteoporosis and fragility fractures
Paul Gerdhem
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2013)
Antipyretic and Anti-inflammatory Effects of Asiaticoside in Lipopolysaccharide-treated Rat through Up-regulation of Heme Oxygenase-1
JingYuan Wan et al.
PHYTOTHERAPY RESEARCH (2013)
Asiaticoside Induces Type I Collagen Synthesis and Osteogenic Differentiation in Human Periodontal Ligament Cells
Nunthawan Nowwarote et al.
PHYTOTHERAPY RESEARCH (2013)
Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors
Preetinder P. Singh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Growth and asiaticoside production in multiple shoot cultures of a medicinal herb, Centella asiatica (L.) Urban, under the influence of nutrient manipulations
Archana Prasad et al.
JOURNAL OF NATURAL MEDICINES (2012)
Glucocorticoid-induced osteonecrosis
Robert S. Weinstein
ENDOCRINE (2012)
NF-κB functions-in osteoclasts
N. S. Soysa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
NF-κB modulators in osteolytic bone diseases
Jiake Xu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2009)
Myocyte Enhancer Factor 2 and Microphthalmia-associated Transcription Factor Cooperate with NFATc1 to Transactivate the V-ATPase d2 Promoter during RANKL-induced Osteoclastogenesis
HaoTian Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Glucocorticoids in osteonecrosis of the femoral head: A new understanding of the mechanisms of action
Mohammad Amin Kerachian et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system
S Tanaka et al.
IMMUNOLOGICAL REVIEWS (2005)
Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-κB inhibitor, through downregulation of NFATc1
H Takatsuna et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells
H Hirotani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
RANKL-induced DC-STAMP is essential for osteoclastogenesis
T Kukita et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Role of osteoclast extracellular signal-regulated kinase (ERK) in cell survival and maintenance of cell polarity
H Nakamura et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappa B activation
C Wang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-κB ligand
JK Xu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-κB ligand (RANKL)
M Matsumoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Reciprocal role of ERK and NF-κB pathways in survival and activation of osteoclasts
T Miyazaki et al.
JOURNAL OF CELL BIOLOGY (2000)
分享论文
